TCT 425: Impact of Coronary Lesion Complexity on 5-Year Outcomes After Bioresorbable Polymer Sirolimus-Eluting Stent Implantation: Insights From the e-ULTIMASTER Registry

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:

• Consultant Fee/Honoraria/Speaker’s Bureau - Abbott; Boston Scientific Corporation; Philips